Private Equity
Institutional investors in North America were mostly overallocated to PE last year, according to Buyouts data. But portfolio value declines helped drive a plurality of them into underallocation.
3 min read · 29 January 2026
As companies stay private for longer, private markets are expanding and offering private wealth investors a broader opportunity set.
3 min read · 29 January 2026
The past few years have tested the patience of LPs who are pushing GPs for exits, writes Adam Spence, of Partners Capital.
4 min read · 28 January 2026
Sovereign funds and insurers are using third-time-round fund stake transactions as part of their portfolio management processes, write Caspar Berendsen, Álvaro Rosado and Robert Perry.
4 min read · 27 January 2026
There's still a lot of hype around AI, and not a lot of hard evidence it will live up to it. But PE firms have found compelling ways to create value with AI at their portfolio companies.
3 min read · 23 January 2026
EQT's acquisition of secondaries pioneer Coller Capital comes as the market for LP stake sales and continuation funds hits new heights.
3 min read · 22 January 2026
Fund III’s limited partners include endowments, foundations, and hospital systems, in addition to existing investors, including Accolade Partners, The David and Lucile Packard Foundation, and Makena Capital Management.
1 min read · 21 January 2026
Accelerating GP demand for fund capital is at odds with today’s supply crunch, caused by widespread LP overallocation.
3 min read · 16 January 2026
Under the TPA an LP’s selling decision is more likely to be driven by opportunistic considerations, rather than breaches of asset allocation targets.
3 min read · 15 January 2026
Fundraising timelines averaged 18.6 months in the North American market last year, down from a record high in 2024, according to Buyouts data.
3 min read · 13 January 2026